Positioning Statement
Latest News

BIO Ventures for Global Health

BIO Ventures for Global Health (BVGH) is a results-oriented nonprofit organization based in Seattle, Washington. BVGH was established in 2004 by the Biotechnology Innovation Organization (BIO) to engage biotechnology, pharmaceutical, and diagnostic companies in meaningful initiatives and programs to impact global health. BVGH programs fall within three categories:

  • R&D for poverty-related diseases
  • Capacity building in low- and middle-income countries
  • Access to medicines

For more information about BVGH, services offered, or current programs download the brochure.


International Drug Companies Join BIO Ventures for Global Health to Tackle Cancer Crisis in Africa

(June 21, 2017) – BVGH is launching the African Access Initiative (AAI) at the Biotechnology Innovation Organization (BIO) International Convention in San Diego. AAI will expand access to oncology medicines and improve cancer care in Africa. Led by BVGH in partnership with Pfizer, Inc., Takeda Pharmaceutical Co., Ltd., and the African Organisation for Research and Training in Cancer (AORTIC), AAI will expand access to oncology medicines and improve cancer care in Africa.  Click here to read more.

Breast Cancer More Aggressive, Deadlier in African Women Than Caucasian Women

(June 20, 2017) –  Dr. Olufunmilayo (Funmi) Olopade, a native of Nigeria and founding director of the Center for Clinical Cancer Genetics at the University of Chicago, has dedicated her career to unraveling breast cancer biology in women of African descent. Her pioneering research, published in leading scientific journals, has shown that the disease "hits earlier and harder" in Africa than among Caucasian women in the United States. BVGH's new African Access Initiative (AAI) will help address the cancer crisis and build the capacity and infrastructure needed to support further research on Africa's cancer landscape and clinical trials of existing and new treatments. Dr. Olopade and Dr. Pol Vandenbroucke, Vice President of the Medical Strategy at Pfizer, will join BVGH's Board of Directors to strengthen its expertise in oncology and healthcare delivery in Africa. Click here to read more.

BIO 2017: A Peek at Pavilions | Sub-Saharan Africa

(May 18, 2017) – The Biotechnology Innovation Organization (BIO) published an article highlighting the Africa Pavilion at the 2017 BIO International Convention as part of their Peek at Pavilions series. Learn about the Africa Pavilion exhibitors and the unique opportunity to "visit" 24 African countries at booth #243 at the BIO Convention in June. Click here to read more.

Cancer Crisis in Africa Prompts BVGH's New African Access Initiative

(May 17, 2017) – In a press release today, BVGH announced that it will expand its programs to address the emerging cancer crisis in Africa. The African Access Initiative (AAI) will provide affordable, sustainable access to cancer therapeutics, enhance healthcare capacity, and foster cancer research in Africa. BVGH will launch its new initiative at the BIO International Convention in San Diego on June 21, 2017. Click here to read more.